Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
J Am Acad Dermatol
; 82(4): 969-979, 2020 Apr.
Article
en En
| MEDLINE
| ID: mdl-31811879
ABSTRACT
Hyperhidrosis is a dermatological condition defined by excessive sweating beyond thermoregulatory needs with significant effects on patients' quality of life. Hyperhidrosis is categorized as primary or secondary primary hyperhidrosis is mostly focal and idiopathic, whereas secondary hyperhidrosis is commonly generalized and caused by an underlying medical condition or use of medications. Various surgical and nonsurgical therapies exist for primary hyperhidrosis. Although botulinum toxin is one of the deadliest toxins known, when used in small doses, it is one of the most effective therapies for primary hyperhidrosis. Botulinum toxin injections are widely used as a second-line primary hyperhidrosis treatment option once topical treatment strategies have failed. This article provides an overview of the commercially available botulinum toxin formulations and their applications in the treatment of primary hyperhidrosis.
Palabras clave
Clostridium bacteria; abobotulinumtoxinA; axillary hyperhidrosis; botulinum neurotoxin; botulinum toxin; craniofacial hyperhidrosis; excessive sweating; incobotulinumtoxinA; onabotulinumtoxinA; palmar hyperhidrosis; plantar hyperhidrosis; prabotulinumtoxinA; primary hyperhidrosis; rimabotulinumtoxinB
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Glándulas Sudoríparas
/
Inyecciones Intradérmicas
/
Toxinas Botulínicas Tipo A
/
Hiperhidrosis
Tipo de estudio:
Etiology_studies
Aspecto:
Patient_preference
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2020
Tipo del documento:
Article